|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, et al: Annual
report on status of cancer in China, 2010. Chin J Cancer Res.
26:48–58. 2014.PubMed/NCBI
|
|
3
|
Maurer CA, Renzulli P, Kull C, et al: The
impact of the introduction of total mesorectal excision on local
recurrence rate and survival in rectal cancer: long-term results.
Ann Surg Oncol. 18:1899–1906. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wiltink LM, Chen TY, Nout RA, et al:
Health-related quality of life 14 years after preoperative
short-term radiotherapy and total mesorectal excision for rectal
cancer: report of a multicenter randomised trial. Eur J Cancer.
50:2390–2398. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sauer R, Liersch T, Merkel S, et al:
Preoperative versus postoperative chemoradiotherapy for locally
advanced rectal cancer: results of the German CAO/ARO/AIO-94
randomized phase III trial after a median follow-up of 11 years. J
Clin Oncol. 30:1926–1933. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sannier A, Lefèvre JH, Panis Y, et al:
Pathological prognostic factors in locally advanced rectal
carcinoma after neoadjuvant radiochemotherapy: analysis of 113
cases. Histopathology. 65:623–630. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dhadda AS, Bessell EM, Scholefield J, et
al: Mandard tumour regression grade, perineural invasion,
circumferential resection margin and post-chemoradiation nodal
status strongly predict outcome in locally advanced rectal cancer
treated with preoperative chemoradiotherapy. Clin Oncol (R Coll
Radiol). 26:197–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Valentini V, Coco C, Picciocchi A, et al:
Does downstaging predict improved outcome after preoperative
chemoradiation for extraperitoneal locally advanced rectal cancer?
A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys.
53:664–674. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fokas E, Liersch T, Fietkau R, et al:
Tumor regression grading after preoperative chemoradiotherapy for
locally advanced rectal carcinoma revisited: updated results of the
CAO/ARO/AIO-94 Trial. J Clin Oncol. 32:1554–1562. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Therasse P, Arbuck SG, Eisenhauer EA, et
al: New guidelines to evaluate the response to treatment in solid
tumors. European Organization for Research and Treatment of Cancer,
National Cancer Institute of the United States, National Cancer
Institute of Canada. J Natl Cancer Inst. 92:205–216. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Curvo-Semedo L, Lambregts DM, Maas M, et
al: Rectal cancer: assessment of complete response to preoperative
combined radiation therapy with chemotherapy-conventional MR
volumetry versus diffusion-weighted MR imaging. Radiology.
260:734–743. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen CC, Lee RC, Lin JK, et al: How
accurate is magnetic resonance imaging in restaging rectal cancer
in patients receiving preoperative combined chemoradiotherapy. Dis
Colon Rectum. 48:722–728. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang JZ, Mayr NA, Zhang D, et al:
Sequential magnetic resonance imaging of cervical cancer: the
predictive value of absolute tumor volume and regression ratio
measured before, during, and after radiation therapy. Cancer.
116:5093–5101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Torkzad M, Lindholm J, Martling A and
Blomqvist L: Retrospective measurement of different size parameters
of non-radiated rectal cancer on MR images and pathology slides and
their comparison. Eur Radiol. 13:2271–2277. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mayr NA, Yuh WT, Taoka T, et al: Serial
therapy-induced changes in tumor shape in cervical cancer and their
impact on assessing tumor volume and treatment response. AJR Am J
Roentgenol. 187:65–72. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kang JH, Kim YC, Kim H, et al: Tumor
volume changes assessed by three-dimensional magnetic resonance
volumetry in rectal cancer patients after preoperative
chemoradiation: the impact of the volume reduction ratio on the
prediction of pathologic complete response. Int J Radiat Oncol Biol
Phys. 76:1018–1025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nougaret S, Rouanet P, Molinari N, et al:
MR volumetric measurement of low rectal cancer helps predict tumor
response and outcome after combined chemotherapy and radiation
therapy. Radiology. 263:409–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yeo SG, Kim DY, Park JW, et al: Tumor
volume reduction rate after preoperative chemoradiotherapy as a
prognostic factor in locally advanced rectal cancer. Int J Radiat
Oncol Biol Phys. 82:e193–e199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang T, Wang J, Deng Y, Wu X and Wang L:
Neoadjuvant therapy followed by local excision and two-stage total
mesorectal excision: a new strategy for sphincter preservation in
locally advanced ultra-low rectal cancer. Gastroenterol Rep (Oxf).
2:37–43. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Barbaro B, Vitale R, Leccisotti L, et al:
Restaging locally advanced rectal cancer with MR imaging after
chemoradiation therapy. Radiographics. 30:699–716. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smith N and Brown G: Preoperative staging
of rectal cancer. Acta Oncol. 47:20–31. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Eisenhauer EA, Therasse P, Bogaerts J, et
al: New response evaluation criteria in solid tumours: revised
RECIST guideline (version 1.1). Eur J Cancer. 45:228–247. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sobin LH and Compton CC: TNM seventh
edition: what's new, what's changed: communication from the
International Union Against Cancer and the American Joint Committee
on Cancer. Cancer. 116:5336–5339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ryan R, Gibbons D, Hyland JM, et al:
Pathological response following long-course neoadjuvant
chemoradiotherapy for locally advanced rectal cancer.
Histopathology. 47:141–146. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
DeLong ER, DeLong DM and Clarke-Pearson
DL: Comparing the areas under two or more correlated receiver
operating characteristic curves: a nonparametric approach.
Biometrics. 44:837–845. 1988. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
den Dulk M, Putter H, Collette L, et al:
The abdominoperineal resection itself is associated with an adverse
outcome: the European experience based on a pooled analysis of five
European randomised clinical trials on rectal cancer. Eur J Cancer.
45:1175–1183. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bosset JF, Collette L, Calais G, et al:
Chemotherapy with preoperative radiotherapy in rectal cancer. N
Engl J Med. 355:1114–1123. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yeo SG, Kim DY, Kim TH, et al: Tumor
volume reduction rate measured by magnetic resonance volumetry
correlated with pathologic tumor response of preoperative
chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys.
78:164–171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Park IJ, You YN, Agarwal A, et al:
Neoadjuvant treatment response as an early response indicator for
patients with rectal cancer. J Clin Oncol. 30:1770–1776. 2012.
View Article : Google Scholar : PubMed/NCBI
|
